Robin Tuytten
0000-0002-8734-7335
36 papers found
Refreshing results…
Cohort profile: Improved Pregnancy Outcomes via Early Detection (IMPROvED), an International Multicentre Prospective Cohort [version 2; peer review: 1 approved]
Cohort profile: Improved Pregnancy Outcomes via Early Detection (IMPROvED), an International Multicentre Prospective Cohort
Preterm preeclampsia screening using biomarkers: combining phenotypic classifiers into robust prediction models
First-trimester preterm preeclampsia prediction with metabolite biomarkers: differential prediction according to maternal body mass index
A step closer to using metabolite biomarkers to improve early pregnancy prediction of preeclampsia
Relationship between the concentration of ergothioneine in plasma and the likelihood of developing pre-eclampsia
Early cost-effectiveness analysis of screening for preeclampsia in nulliparous women: A modelling approach in European high-income settings
A machine learning algorithm to differentiate bipolar disorder from major depressive disorder using an online mental health questionnaire and blood biomarker data
Diagnostic prediction model development using data from dried blood spot proteomics and a digital mental health assessment to identify major depressive disorder among individuals presenting with low mood
Prediction of preeclampsia risk in first time pregnant women: Metabolite biomarkers for a clinical test
Metabolite Biomarkers for Early Prediction of Pre-Eclampsia in Women with Obesity.
Revealing of endogenous Marinobufagin by an ultra-specific and sensitive UHPLC-MS/MS assay in pregnant women
A novel method for interrogating receiver operating characteristic curves for assessing prognostic tests
P88. Pre-eclampsia risk stratification for low risk 1st pregnancies: First results of a new LC-MS based multiplex metabolite assay
O16. Marinobufagenin as a promising preeclampsia risk assessment marker: purification from toad venom and LC–MS identification in human plasma
[158-Pos]
Mid-trimester maternal ADAM12 levels differ according to fetal gender in pregnancies complicated by preeclampsia
Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia
OS043. Identification and validation of novel markers for the predictionof pre-eclampsia
Unbiased plasma proteomics for novel diagnostic biomarkers in cardiovascular disease: identification of quiescin Q6 as a candidate biomarker of acutely decompensated heart failure
Missing publications? Search for publications with a matching author name.